Premium
Steroid‐Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials
Author(s) -
Klintmalm G. B.,
Vincenti F.,
Kirk A.
Publication year - 2016
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.13889
Subject(s) - medicine , calcineurin , nephrotoxicity , immunosuppression , surgery , septic shock , transplantation , kidney , sepsis
Development of new immunosuppressive regimens for transplantation has come to a standstill, leading the authors to urge for substantial change of the current regulatory requirements and endpoints for new agent approval.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom